Ryne Sandberg, Hall of Fame and prostate cancer
Digest more
The constant threat of recurrence feels like the proverbial sword of Damocles — always present, always waiting. If my cancer does return, the now-inert metal seeds scattered through my prostate and the scar tissue caused by the radiation greatly complicate my future treatment options.
Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos Vargas,
Prostate cancer is the most common form of cancer among men in England, with cases surging among both men and women by 25 per cent between 2019 and 2023 according to NHS data. It’s also the second deadliest form of the disease for men after lung cancer,
The House Committee on Oversight and Government Reform has expanded its investigation of the cover-up of former President Joe Biden’s health, prostate cancer, and mental decline. On June 4, Chairman James Comer subpoenaed five former senior White House aides to appear for transcribed interviews in addition to Biden’s physician,
Prostate cancer is the second leading cause of death in men right behind heart disease. Patients with this cancer often don’t find out until the disease has advanced quite a bit. But there are some signs to watch for — and a new test to identify prostate cancer.
Explore more
The global statistics are terrifying. Prostate cancer is the fourth most common cancer in all populations, the second most common cancer among men worldwide, and ranks first in Europe where a third of men who die from cancer will die because of prostate cancer.
5d
MedPage Today on MSNFracture Risk Down With Osteoporosis Drug in Metastatic Prostate CancerWith regard to the choice of bone-protecting agent, denosumab (Xgeva) improved bone density and reduced fracture risk in a placebo-controlled trial involving men with non-metastatic HSPC. Denosumab outperformed zoledronic acid for preventing SREs in men with metastatic castration-resistant prostate cancer.